BioMarin Pharmaceutical Inc
BMRN· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $236.74M | $202.92M | $151.55M | $127.93M |
| Net Income | -$83.05M | -$67.50M | -$38.12M | -$39.81M |
| EPS Diluted | -$0.51 |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.43 |
| -$0.27 |
| -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.